Your browser doesn't support javascript.
loading
Vaccination with Vaxfectin(®) adjuvanted SIV DNA induces long-lasting humoral immune responses able to reduce SIVmac251 Viremia.
Kulkarni, Viraj; Rosati, Margherita; Valentin, Antonio; Jalah, Rashmi; Alicea, Candido; Yu, Lei; Guan, Yongjun; Shen, Xiaoying; Tomaras, Georgia D; LaBranche, Celia; Montefiori, David C; Irene, Carmela; Prattipati, Rajasekhar; Pinter, Abraham; Sullivan, Sean M; Pavlakis, George N; Felber, Barbara K.
Afiliação
  • Kulkarni V; Human Retrovirus Pathogenesis Section; Vaccine Branch; Center for Cancer Research; National Cancer Institute; Frederick, MD USA.
  • Rosati M; Human Retrovirus Section; Vaccine Branch; Center for Cancer Research; National Cancer Institute; Frederick, MD USA.
  • Valentin A; Human Retrovirus Section; Vaccine Branch; Center for Cancer Research; National Cancer Institute; Frederick, MD USA.
  • Jalah R; Human Retrovirus Pathogenesis Section; Vaccine Branch; Center for Cancer Research; National Cancer Institute; Frederick, MD USA.
  • Alicea C; Human Retrovirus Pathogenesis Section; Vaccine Branch; Center for Cancer Research; National Cancer Institute; Frederick, MD USA.
  • Yu L; Institute of Human Virology and Department of Microbiology & Immunology; University of Maryland School of Medicine; Baltimore, MD USA.
  • Guan Y; Institute of Human Virology and Department of Microbiology & Immunology; University of Maryland School of Medicine; Baltimore, MD USA.
  • Shen X; Duke Human Vaccine Institute; Durham, NC USA.
  • Tomaras GD; Duke Human Vaccine Institute; Durham, NC USA.
  • LaBranche C; Duke Human Vaccine Institute; Durham, NC USA.
  • Montefiori DC; Duke Human Vaccine Institute; Durham, NC USA.
  • Irene C; Public Health Research Institute; University of Medicine and Dentistry of New Jersey; Newark, NJ USA.
  • Prattipati R; Public Health Research Institute; University of Medicine and Dentistry of New Jersey; Newark, NJ USA.
  • Pinter A; Public Health Research Institute; University of Medicine and Dentistry of New Jersey; Newark, NJ USA.
  • Sullivan SM; Vical Inc.; Pharmaceutical Sciences; San Diego, CA USA.
  • Pavlakis GN; Human Retrovirus Section; Vaccine Branch; Center for Cancer Research; National Cancer Institute; Frederick, MD USA.
  • Felber BK; Human Retrovirus Pathogenesis Section; Vaccine Branch; Center for Cancer Research; National Cancer Institute; Frederick, MD USA.
Hum Vaccin Immunother ; 9(10): 2069-80, 2013 Oct.
Article em En | MEDLINE | ID: mdl-23820294
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Fosfatidiletanolaminas / Viremia / Adjuvantes Imunológicos / Vacinação / Vacinas contra a SAIDS / Vacinas de DNA / Imunidade Humoral Limite: Animals Idioma: En Revista: Hum Vaccin Immunother Ano de publicação: 2013 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Fosfatidiletanolaminas / Viremia / Adjuvantes Imunológicos / Vacinação / Vacinas contra a SAIDS / Vacinas de DNA / Imunidade Humoral Limite: Animals Idioma: En Revista: Hum Vaccin Immunother Ano de publicação: 2013 Tipo de documento: Article